Code | 8001E | ||||||||||
MA number | 26/0299/24-S | ||||||||||
Product Form: | plc ifc 1x100 mg (liek.inj.skl.) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Accord Healthcare Polska Sp. z o.o., Poland | ||||||||||
Therapeutic Class: | 26 - ANTIMYCOTICA (LOKÁLNE A CELKOVÉ) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 18.12.2024 |
Validity: | 18.12.2029 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
SPC: |
|
PIL: |
|
Safety feature | Yes |
Data update: | 19.12.2024 |